CCL20 produced in the cytokine network of rheumatoid arthritis recruits CCR6+ mononuclear cells and enhances the production of IL-6

Cytokine

Volumn 47, Issue 2, 2009, Pages 112-118

  Tanida, Shimei ^a   Yoshitomi, Hiroyuki ^a   Nishitani, Kohei ^a   Ishikawa, Masahiro ^a   Kitaori, Toshiyuki ^a   Ito, Hiromu ^a   Nakamura, Takashi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CCL20; IL 1; IL 17; IL 6; Rheumatoid arthritis

Indexed keywords

CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HUMAN; HUMAN CELL; INFLAMMATION; MECHANICAL STRESS; MONONUCLEAR CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVITIS;

ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CHEMOKINE CCL20; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; RECEPTORS, CCR6; SYNOVIAL MEMBRANE; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650642275     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2009.05.009     Document Type: Article

References (35)

1. Lipsky P.E. Why does rheumatoid arthritis involve the joints?. N Engl J Med 356 (2007) 2419-2420
2. Nanki T., Nagasaka K., Hayashida K., Saita Y., and Miyasaka N. Chemokines regulate IL-6 and IL-8 production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Immunol 167 (2001) 5381-5385
3. Luster A.D. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
4. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 423 (2003) 356-361
5. Desmetz C., Lin Y.L., Mettling C., Portales P., Noel D., Clot J., et al. Cell surface CCR5 density determines the intensity of T cell migration towards rheumatoid arthritis synoviocytes. Clin Immunol 123 (2007) 148-154
6. Pene J., Chevalier S., Preisser L., Venereau E., Guilleux M.H., Ghannam S., et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 180 (2008) 7423-7430
7. Vergunst C.E., Gerlag D.M., Lopatinskaya L., Klareskog L., Smith M.D., van den Bosch F., et al. Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 58 (2008) 1931-1939
8. Toh M.L., and Miossec P. The role of T cells in rheumatoid arthritis: new subsets and new targets. Curr Opin Rheumatol 19 (2007) 284-288
9. Lubberts E. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?. Cytokine 41 (2008) 84-91
10. Rollins B. Chemokines. Blood 90 (1997) 909-928
11. Mackay C. Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat Immunol 9 (2008) 988-998
12. Murphy G., Caplice N., and Molloy M. Fractalkine in rheumatoid arthritis: a review to date (2008), Rheumatology, Oxford
13. Lenoir M., Djerdjouri B., and Périanin A. Stroma cell-derived factor 1alpha mediates desensitization of human neutrophil respiratory burst in synovial fluid from rheumatoid arthritic patients. J Immunol 172 (2004) 7136-7143
14. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 204 (2007) 2803-2812
15. Schutyser E., Struyf S., and Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 14 (2003) 409-426
16. Matsui T., Akahoshi T., Namai R., Hashimoto A., Kurihara Y., Rana M., et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3 alpha in rheumatoid arthritis. Clin Exp Immunol 125 (2001) 155-161
17. Nakae S., Saijo S., Horai R., Sudo K., Mori S., and Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100 (2003) 5986-5990
18. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
19. Chabaud M., Page G., and Miossec P. Enhancing effect of IL-1, IL-17, and TNF-alpha on macrophage inflammatory protein-3alpha production in rheumatoid arthritis: regulation by soluble receptors and Th2 cytokines. J Immunol 167 (2001) 6015-6020
20. Chevrel G., Garnero P., and Miossec P. Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation. Ann Rheum Dis 61 (2002) 730-733
21. Hiramitsu T., Yasuda T., Ito H., Shimizu M., Julovi S.M., Kakinuma T., et al. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38. Rheumatology (Oxford) 45 (2006) 824-832
22. Wang X., and Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31 (2003) e154
23. Res P., Blom B., Hori T., Weijer K., and Spits H. Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development. J Exp Med 185 (1997) 141-151
24. Mihara M., Moriya Y., Kishimoto T., and Ohsugi Y. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br J Rheumatol 34 (1995) 321-325
25. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
26. + regulatory T cells in autoimmune diseases. Nat Clin Pract Rheumatol 3 (2007) 619-626
27. Boyle D.L., Nguyen K.H., Zhuang S., Shi Y., McCormack J.E., Chada S., et al. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced th2activity. Gene Ther 6 (1999) 1911-1918
28. McDonald A.H., and Swanborg R.H. Antigen-specific inhibition of immune interferon production by suppressor cells of autoimmune encephalomyelitis. J Immunol 140 (1988) 1132-1138
29. Voorthuis J., Uitdehaag B., De Groot C., Goede P., van der Meide P., and Dijkstra C. Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol 81 (1990) 183-188
30. Willenborg D., Fordham S., Staykova M., Ramshaw I., and Cowden W. IFN-gamma is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol 163 (1999) 5278-5286
31. Ruth J.H., Shahrara S., Park C.C., Morel J.C., Kumar P., Qin S., et al. Role of macrophage inflammatory protein-3alpha and its ligand CCR6 in rheumatoid arthritis. Lab Invest 83 (2003) 579-588
32. Garcia-Vicuna R., Gomez-Gaviro M.V., Dominguez-Luis M.J., Pec M.K., Gonzalez-Alvaro I., Alvaro-Gracia J.M., et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum 50 (2004) 3866-3877
33. Acosta-Rodriguez E., Napolitani G., Lanzavecchia A., and Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 8 (2007) 942-949
34. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
35. Lisignoli G., Piacentini A., Cristino S., Grassi F., Cavallo C., Cattini L., et al. CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. J Cell Physiol 210 (2007) 798-806